Clinical Trial · NCT04769817

Prostate Cancer Theranostics and Imaging Centre of Excellence (ProsTIC) Prospective Patient Registry of Men Treated With PSMA Theranostics

Overview

This is a descriptive, observational, prospective, open-ended, registry utilising electronic data capture to collect information on the outcomes of men treated with prostate specific-membrane antigen (PSMA) theranostics.

Sponsor

Peter MacCallum Cancer Centre

Phase

N/A

Contacts

Elizabeth Medhurst

prostic@petermac.org

+61 3 8559 8617

Gaurav Sharma

gaurav.sharma@petermac.org

03 85596830

ClinicalTrials.gov

NCT04769817